321 related articles for article (PubMed ID: 8567095)
1. Comparison of the effects of chlormadinone acetate-pellet implantation and orchidectomy on benign prostatic hypertrophy in the dog.
Kawakami E; Tsutsui T; Shimizu M; Orima H; Fujita M; Ogasa A
Int J Androl; 1995 Oct; 18(5):248-55. PubMed ID: 8567095
[TBL] [Abstract][Full Text] [Related]
2. Chlormadinone acetate pellet implantation plus short-term oral administration in dogs with benign prostatic hypertrophy.
Kawakami E; Shimizu M; Orima H; Fujita M; Hori T; Tsutsui T
Int J Androl; 1998 Apr; 21(2):67-73. PubMed ID: 9675615
[TBL] [Abstract][Full Text] [Related]
3. Effect of antiandrogen, chlormadinone acetate (CMA), in canine spontaneous benign prostatic hyperplasia (BPH).
Murakoshi M; Ikada R; Tagawa M; Nakayama T
Tokai J Exp Clin Med; 2000 Apr; 25(1):11-4. PubMed ID: 11023050
[TBL] [Abstract][Full Text] [Related]
4. Effects of oral administration of chlormadinone acetate on canine prostatic hypertrophy.
Kawakami E; Tsutsui T; Shimizu M; Orima H; Makanae Y; Yajima K; Ogasa A
J Vet Med Sci; 1993 Aug; 55(4):631-5. PubMed ID: 7691191
[TBL] [Abstract][Full Text] [Related]
5. Effect of chlormadinone acetate-pellet implantation on the volume of prostate, peripheral blood levels of sex hormones and semen quality in the dog.
Shimizu M; Tsutsui T; Kawakami E; Hori T; Fujita M; Orima H; Ogasa A
J Vet Med Sci; 1995 Jun; 57(3):395-9. PubMed ID: 7548388
[TBL] [Abstract][Full Text] [Related]
6. Effect of osaterone acetate administration on prostatic regression rate, peripheral blood hormone levels and semen quality in dogs with benign prostatic hypertrophy.
Tsutsui T; Hori T; Shimizu M; Tatsuzawa C; Kawakami E
J Vet Med Sci; 2001 Apr; 63(4):453-6. PubMed ID: 11346183
[TBL] [Abstract][Full Text] [Related]
7. Improvement in spermatogenic function after subcutaneous implantation of a capsule containing an aromatase inhibitor in four oligozoospermic dogs and one azoospermic dog with high plasma estradiol-17beta concentrations.
Kawakami E; Hirano T; Hori T; Tsutsui T
Theriogenology; 2004 Jul; 62(1-2):165-78. PubMed ID: 15159111
[TBL] [Abstract][Full Text] [Related]
8. Relationship between prostatic atrophy and apoptosis in the canine spontaneous benign prostatic hyperplasia (BPH) following chlormadinone acetate (CMA).
Murakoshi M; Ikeda R; Fukui N; Nakayama T
Tokai J Exp Clin Med; 2001 Jul; 26(2):71-5. PubMed ID: 11806444
[TBL] [Abstract][Full Text] [Related]
9. Comparison of histological compositions and apoptosis in canine spontaneous benign prostatic hyperplasia treated with androgen suppressive agents chlormadinone acetate and finasteride.
Shibata Y; Fukabori Y; Ito K; Suzuki K; Yamanaka H
J Urol; 2001 Jan; 165(1):289-93. PubMed ID: 11125427
[TBL] [Abstract][Full Text] [Related]
10. Immunolocalization of androgen receptor in canine prostatic hyperplasia--effect of antiandrogen.
Murakoshi M; Ikeda R; Tagawa M; Nakayama T; Honma S; Mieda M
Tokai J Exp Clin Med; 1998 Nov; 23(5):209-12. PubMed ID: 10418722
[TBL] [Abstract][Full Text] [Related]
11. Effects of combination therapy with a luteinizing hormone-releasing hormone agonist and chlormadinone acetate on rat prostate weight and plasma testosterone levels.
Gotanda K; Shinbo A; Okada M; Nakano Y; Kobayashi H; Sasaki T; Hagiwara M; Akaza H
Prostate Cancer Prostatic Dis; 2003; 6(1):66-72. PubMed ID: 12664069
[TBL] [Abstract][Full Text] [Related]
12. Short-term oral treatment of canine benign prostatic hypertrophy with chlormadinone acetate.
Orima H; Shimizu M; Tsutsui T; Kawakami E; Ogasa A
J Vet Med Sci; 1995 Feb; 57(1):139-41. PubMed ID: 7538794
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the clinical efficacy of Gonazon implants in the treatment of reproductive pathologies, behavioral problems, and suppression of reproductive function in the male dog.
Goericke-Pesch S; Wilhelm E; Ludwig C; Desmoulins PO; Driancourt MA; Hoffmann B
Theriogenology; 2010 Apr; 73(7):920-6. PubMed ID: 20097413
[TBL] [Abstract][Full Text] [Related]
14. Prostate-specific antigen changes as a result of chlormadinone acetate administration to patients with benign prostatic hyperplasia: a retrospective multi-institutional study.
Fujimoto K; Hirao Y; Masumori N; Arai Y; Yamanaka H; Kato T; Miyazawa K
Int J Urol; 2006 May; 13(5):543-9. PubMed ID: 16771723
[TBL] [Abstract][Full Text] [Related]
15. [Changes in serum prostate specific antigen and testosterone levels after chlormadinone acetate treatment in patients with benign prostatic hyperplasia : a prospective multicenter clinical study].
Fujimoto K; Hirao Y; Ohashi Y; Shibata Y; Fuji K; Tsuji H; Shimizu N; Miyazawa K; Nagata M; Ohtani N; Furuya R; Boku E
Hinyokika Kiyo; 2011 Apr; 57(4):177-83. PubMed ID: 21646847
[TBL] [Abstract][Full Text] [Related]
16. [Clinical studies on morphological changes in the prostate in patients with benign prostatic hypertrophy after antiandrogen therapy--by means of transrectal ultrasonotomography].
Suzuki K; Ichinose Y; Hashimoto K; Matsumoto K; Suzuki T; Imai K; Yamanaka H
Hinyokika Kiyo; 1990 May; 36(5):557-60. PubMed ID: 1698012
[TBL] [Abstract][Full Text] [Related]
17. Reversible downregulation of endocrine and germinative testicular function (hormonal castration) in the dog with the GnRH-agonist azagly-nafarelin as a removable implant "Gonazon"; a preclinical trial.
Ludwig C; Desmoulins PO; Driancourt MA; Goericke-Pesch S; Hoffmann B
Theriogenology; 2009 Apr; 71(7):1037-45. PubMed ID: 19233456
[TBL] [Abstract][Full Text] [Related]
18. The effects of chlormadinone acetate (CMA), antiandrogen, on the pituitary, testis, prostate and adrenal gland of the dog with spontaneous benign prostatic hyperplasia.
Murakoshi M; Ikeda R; Fukui N
J Toxicol Sci; 2001 Aug; 26(3):119-27. PubMed ID: 11552295
[TBL] [Abstract][Full Text] [Related]
19. Histopathological study of female beagle dogs for four year treatment with subcutaneous implantation of chlormadinone acetate (CMA).
Murakoshi M; Ikeda R; Tagawa M; Iwasaka T; Nakayama T
Tokai J Exp Clin Med; 2000 Oct; 25(3):87-91. PubMed ID: 11368213
[TBL] [Abstract][Full Text] [Related]
20. Ultrastructural study in canine prostatic hyperplasia--effect of antiandrogen.
Murakoshi M; Masuda S; Ikeda R; Tagawa M; Nakayama T; Honma S; Mieda M
Tokai J Exp Clin Med; 1998 Nov; 23(5):245-8. PubMed ID: 10418729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
